|
Professor SHI Weiqun's experience in treating nonalcoholic fatty liver disease |
Hits 1317 Download times 1005 Received:November 20, 2019 |
View Full Text View/Add Comment Download reader |
DOI
10.11656/j.issn.1673-9043.2020.01.06 |
Key Words
nonalcoholic fatty liver disease;Chinese medicine treatment;experience summary;SHI Weiqun |
Author Name | Affiliation | E-mail | LI Feng | Traditional Chinese Medicine University, Second Clinical Medical College, Hangzhou 310053, China | | LUO Shuirong | Traditional Chinese Medicine University, Second Clinical Medical College, Hangzhou 310053, China | | ZENG Ruxue | Jiangshan People's Hospital, Quzhou 324100, China | | LAI Jiefeng | Traditional Chinese Medicine University, Second Clinical Medical College, Hangzhou 310053, China | | SHI Weiqun | Shi weiqun Famous Traditional Chinese Medicine Experts Inheritance Studio, Hangzhou 310011, China The Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Hangzhou 310011, China | 13018900041@126.com |
|
Abstract
|
Nonalcoholic fatty liver disease is a disease with no history of excessive drinking. The triacylglycerol in patients' liver cells is significantly higher than normal and diffuse degeneration of hepatic cells. With the development of social economy,the incidence of nonalcoholic fatty liver disease is increasing year by year,and it has become the first major chronic liver disease that seriously endangers the health of the people. From a long-term perspective,the side effects of western medicine are relatively large,which cannot improve the quality of life of patients. Professor SHI Weiqun is now the provincial famous Chinese medicine doctor who has more than 40 years of experience in clinical work of traditional Chinese medicine. This article describes the experience of Professor SHI Weiqun in the treatment of nonalcoholic fatty liver disease from the etiology and pathogenesis,and discusses the exact curative effect of Chinese medicine on nonalcoholic fatty liver disease. Clinical application and application to better inherit the development of motherland medicine. |
|
|
|
|
|